In combating COVID-19, science is how we get back to normal

Lori Reilly
Lori Reilly June 24, 2020

In combating COVID-19, science is how we get back to normal.

Share This

America’s biopharmaceutical companies are working around the clock to combat a common enemy: COVID-19. As the fight to research and develop innovative treatments and vaccines advances, I’m pleased to share our new TV ad, highlighting how we are working together to help end the global pandemic. Beginning today, the ad will appear on national cable and broadcast channels as well as online.



In the ad, three scientists detail how the biopharmaceutical industry is making progress to develop treatment and vaccine candidates against COVID-19 by collaborating in ways we’ve never done before.


We’ve made incredible progress in a matter of weeks, as we now have several vaccine candidates along with potential therapeutics that have shown positive results. Today, there are over 1,200 clinical trials for treatments and vaccines for COVID-19. Already, there are 13 vaccines in active clinical trials with over 120 in preclinical testing; these trials are occurring across 45 states and the District of Columbia.


In creating this ad, we’re proud to highlight several inspiring scientists that represent the more than 140,000 researchers across the country who are looking for vaccines, treatments and cures for coronavirus and other diseases. The three scientists in this ad also reflect the strong role women play in the life sciences industry, where women account for nearly half of the workforce up from just a third in 1990.

To learn more about biopharmaceutical efforts to combat coronavirus, visit PhRMA.org/Coronavirus.

Topics: Research and Development, PhRMA Member Company, Coronavirus